Annual report pursuant to Section 13 and 15(d)

WARRANTS (Details Narrative)

v3.20.4
WARRANTS (Details Narrative) - USD ($)
 12 Months Ended
Oct. 16, 2020
Jul. 28, 2020
Dec. 31, 2020
Dec. 31, 2019
Jun. 28, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Issuance of common stock upon exercise of stock options, shares     427,611 107,029  
Fair value of warrants issued     $ 6,215,225    
Debt face amount     $ 20,000,000    
Share-based Payment Arrangement, Tranche One [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Debt face amount   $ 20,000,000      
Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised   86,206      
Exercise price of warrants   $ 6.96      
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Debt face amount         $ 50,000,000
Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised     0 1,283,500  
Issuance of common stock upon exercise of stock options, shares       1,119,868  
Warrant [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants to purchase shares of common stock, exercised   86,206      
Exercise price of warrants   $ 6.96      
Warrant expire date   Jul. 28, 2030      
Fair value of warrants issued   $ 472,409      
Warrant [Member] | Professional Services Agreement [Member] | Investor Relations Service Provider [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares 420,000        
Exercise price of warrants $ 1.07        
Fair value of warrants issued $ 334,740        
CFF Warrant [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares     1,000,000    
Exercise price of warrants     $ 13.20    
CFF Warrant [Member] | Investment Agreement [Member]          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Warrants outstanding to purchase of common stock shares     1,506,206    
Exercise price of warrants     $ 9.46    
Weighted average remaining life of warrants     4 years 7 months 6 days    
Number of warrants exercisable for common stock     500,000    
Warrant expire date     Jan. 26, 2025